Share Capital |
a)Authorized capital The Company is authorised to issue an unlimited number of common voting shares without nominal or par value. During the nine months ended March 31, 2024, the Company issued a total of 100,000 common shares for the exercise of stock options. The Company received proceeds of $140 and reclassified $126 from reserve to share capital upon exercise. During the nine months ended March 31, 2023, the Company issued a total of 5,750,000 common shares for the exercise of stock options. The Company received proceeds of $5,257 and reclassified $2,967 from reserve to share capital upon exercise. During the nine months ended March 31, 2024, the Company issued 9,320,559 common shares for proceeds of $19,263 net of transaction costs of $1,504 under the Company’s ATM offering (March 31, 2023: $Nil). b)Options The Company has a stock option plan in place under which it is authorized to grant options to officers, directors, consultants, management and company employees enabling them to cumulatively acquire up to 10% of the issued and outstanding common stock of the Company. Under the plan, the exercise price of each option shall not be less than the price permitted by any stock exchange. The options can be granted for a maximum term of 10 years. The weighted average fair value at grant date of options granted during the nine months ended March 31, 2024 was $2.61 per option (June 30, 2023: $3.45). The fair value was determined using the Black-Scholes option-pricing model using the following weighted average assumptions: | | | | | | | | | | YTD2024 | | FY2023 | | Expected stock price volatility | | | 77 | % | | 84 | % | Risk-free interest rate | | | 4.4 | % | | 3.16 | % | Dividend yield | | | — | | | — | | Expected life of options | | | 5 years | | | 5 years | | Stock price on date of grant | | $ | 4.00 | | $ | 5.09 | | Forfeiture rate | | | — | | | — | |
Stock option transactions are summarized as follows: | | | | | | | | Number of | | Weighted average | | | options | | exercise price | Balance at June 30, 2022 | | 10,170,000 | | $ | 2.11 | Options exercised | | (5,950,000) | | | 0.91 | Options granted | | 3,950,000 | | | 5.09 | Balance at June 30, 2023 | | 8,170,000 | | $ | 4.43 | Options exercised | | (100,000) | | | 1.40 | Options granted | | 1,750,000 | | | 4.00 | Balance at March 31, 2024 | | 9,820,000 | | $ | 4.38 |
8. | Share Capital - continued |
b)Options - continued The following table summarizes stock options outstanding and exercisable at March 31, 2024: | | | | | | | | | | | | Options Outstanding | | Options Exercisable | | | | | Weighted | | Weighted | | | | Weighted | | | | | Average | | Average | | | | Average | Exercise | | Number | | Remaining | | Exercise | | | | Exercise | Price | | of | | Contractual Life | | Price | | Number | | Price | $ | | Shares | | (years) | | $ | | Exercisable | | $ | 1.40 | | 1,350,000 | | — | (1) | 1.40 | | 1,350,000 | | 1.40 | 3.43 | | 400,000 | | 0.04 | | 3.43 | | 400,000 | | 3.43 | 7.55 | | 500,000 | | 0.87 | | 7.55 | | 500,000 | | 7.55 | 3.39 | | 1,200,000 | | 1.80 | | 3.39 | | 1,200,000 | | 3.39 | 6.08 | | 200,000 | | 2.30 | | 6.08 | | 200,000 | | 6.08 | 6.31 | | 200,000 | | 2.93 | | 6.31 | | 200,000 | | 6.31 | 8.25 | | 170,000 | | 2.96 | | 8.25 | | 170,000 | | 8.25 | 9.40 | | 100,000 | | 3.03 | | 9.40 | | 100,000 | | 9.40 | 5.08 | | 3,750,000 | | 4.03 | | 5.08 | | 3,750,000 | | 5.08 | 5.23 | | 200,000 | | 4.15 | | 5.23 | | 200,000 | | 5.23 | 4.00 | | 1,750,000 | | 4.48 | | 4.00 | | 433,333 | | 4.00 | | | 9,820,000 | | 2.88 | | 4.38 | | 8,503,333 | | 4.44 |
(1) | Options expired on September 4, 2023, however, due to black-out of insider share transactions, these options will remain eligible for exercise for a period of 10 business days subsequent to the lifting of the black-out. |
c) Long-term Incentive Plan The Company has an equity incentive plan (“Plan”) in accordance with the policies of the TSX Venture Exchange whereby, from time to time at the discretion of the Board of Directors, eligible directors, officers and employees are awarded restricted share units (“RSUs”) and performance share units (“PSUs”). The RSUs and PSUs that are subject to the recipient’s deferral right in accordance with the Income Tax Act (Canada) convert automatically into common shares upon vesting. In addition, the Company may issue deferred share units (“DSUs”). DSUs may be redeemed upon retirement or termination from the Company. The plan is a fixed plan pursuant to which the aggregate number of common shares to be issued shall not exceed 10% of the Company’s issued and outstanding common shares when combined with the aggregate number of Options, RSUs, PSUs and DSUs. As of March 31, 2024, the Company has granted 1,991,004 DSUs to the Board of Directors and Management which vested on April 11, 2024. The Company has recorded $4,929 in share-based payment expense related to this grant during the nine-month period ended March 31, 2024.
|